Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
出版年份 2022 全文链接
标题
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
作者
关键词
-
出版物
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-08-09
DOI
10.1016/s1473-3099(22)00291-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
- (2022) Laura L. Hammitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
- (2021) Jerald Sadoff et al. JOURNAL OF INFECTIOUS DISEASES
- Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
- (2021) Tracy J Ruckwardt et al. Lancet Respiratory Medicine
- Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies
- (2021) Padmini Srikantiah et al. CLINICAL INFECTIOUS DISEASES
- Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom
- (2021) F Zeevat et al. JOURNAL OF INFECTIOUS DISEASES
- Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus
- (2021) Pierre-Louis Hervé et al. VACCINE
- An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
- (2021) Armando Zuniga et al. npj Vaccines
- Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
- (2021) Jintanat Ananworanich et al. Vaccines
- Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
- (2021) William L. Herring et al. VACCINE
- Vaccine-induced immune thrombotic thrombocytopenia
- (2021) Frederikus A Klok et al. Lancet Haematology
- Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
- (2021) Brian M. Maas et al. EBioMedicine
- LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study
- (2021) Ann R Falsey et al. Open Forum Infectious Diseases
- Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
- (2020) Elizabeth J McFarland et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
- (2020) Nathaly Samy et al. VACCINE
- A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
- (2020) Steffen Mueller et al. VACCINE
- Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
- (2020) Xiao Li et al. BMC Medicine
- Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years
- (2020) Kristi Williams et al. JOURNAL OF INFECTIOUS DISEASES
- Broad Antibody and Cellular Immune Response from a Phase 2 Clinical Trial with a Novel Multivalent Poxvirus Based RSV Vaccine
- (2020) Elke Jordan et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
- (2020) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
- (2020) M. Pamela Griffin et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial
- (2020) Pauline Verdijk et al. VACCINE
- Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein
- (2020) Heather L. Torrey et al. Human Vaccines & Immunotherapeutics
- Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults
- (2020) Felicia Scaggs Huang et al. Human Vaccines & Immunotherapeutics
- Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice
- (2020) Leslie van der Fits et al. npj Vaccines
- Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children
- (2020) Ruth A Karron et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
- (2020) Eric A F Simões et al. CLINICAL INFECTIOUS DISEASES
- Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults
- (2020) Jerald Sadoff et al. JOURNAL OF INFECTIOUS DISEASES
- Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
- (2020) Benjamin Lee Human Vaccines & Immunotherapeutics
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
- (2019) Jessica Marcandalli et al. CELL
- First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults
- (2019) Paola Cicconi et al. CLINICAL INFECTIOUS DISEASES
- A proof of concept for structure-based vaccine design targeting RSV in humans
- (2019) Michelle C. Crank et al. SCIENCE
- An ethics framework and practical guidance for post-trial access to an RSV maternal vaccine
- (2019) Natalie I Mazur et al. Lancet Respiratory Medicine
- Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children
- (2019) Ruth A Karron et al. JOURNAL OF INFECTIOUS DISEASES
- A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
- (2019) Aimin Tang et al. Nature Communications
- Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis
- (2019) Shanshan Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study
- (2018) Joanne M Langley et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897
- (2018) Qing Zhu et al. JOURNAL OF INFECTIOUS DISEASES
- The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
- (2018) Natalie I Mazur et al. LANCET INFECTIOUS DISEASES
- Down Syndrome and the Risk of Severe RSV Infection: A Meta-analysis
- (2018) Andrea A. Beckhaus et al. PEDIATRICS
- Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults
- (2018) Bradley Ackerson et al. CLINICAL INFECTIOUS DISEASES
- A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease
- (2017) Marian Alexander Wiegand et al. JOURNAL OF VIROLOGY
- Maternal Immunization
- (2017) Saad B. Omer NEW ENGLAND JOURNAL OF MEDICINE
- Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure
- (2017) Cyril Le Nouën et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
- (2017) Nienke M Scheltema et al. Lancet Global Health
- Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization
- (2016) Vincent Ahonkhai et al. PLoS One
- A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation
- (2016) Christopher C. Stobart et al. Nature Communications
- Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
- (2016) April M. Killikelly et al. Scientific Reports
- Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization
- (2016) Marta C. Nunes et al. JAMA Pediatrics
- Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
- (2015) Maximillian S. Habibi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- (2015) Joan O. Ngwuta et al. Science Translational Medicine
- A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
- (2015) Anders Krarup et al. Nature Communications
- RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
- (2015) Agnieszka Jozwik et al. Nature Communications
- RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets
- (2015) Cory J. Knudson et al. PLoS Pathogens
- Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics
- (2015) Natalie I Mazur et al. Lancet Respiratory Medicine
- Maternal Immunization
- (2014) H. Y. Chu et al. CLINICAL INFECTIOUS DISEASES
- Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh
- (2014) Helen Y. Chu et al. JOURNAL OF INFECTIOUS DISEASES
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- Strategic priorities for respiratory syncytial virus (RSV) vaccine development
- (2013) L.J. Anderson et al. VACCINE
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
- (2011) J. S. McLellan et al. JOURNAL OF VIROLOGY
- Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
- (2011) Harish Nair et al. LANCET
- Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes
- (2009) Bernhard Resch et al. Paediatric Respiratory Reviews
- Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze
- (2008) Lone Graff Stensballe et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now